Sophia Genetics SA balance sheet

At the end of fiscal 2025, Sophia Genetics SA had total assets of $163m, total liabilities of $116m and shareholders' equity of $47.1m. It held $70.3m in cash against $47.7m of debt: net cash of $22.6m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Sophia Genetics SA: balance sheet, annual
Fiscal year	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	18	75	193	161	123	80	70
Receivables	—	6	6	7	14	7	15
Inventory	—	3	6	5	6	6	6
Total current assets	—	110	283	196	148	99	99
Total assets	—	132	320	244	206	155	163
Total current liabilities	—	22	29	27	36	27	51
Short-term debt	—	3	—	—	—	—	—
Long-term debt	—	0	—	—	0	13	48
Total debt	4	3	0	0	0	13	48
Total liabilities	—	32	45	44	55	59	116
Shareholders' equity	22	101	275	200	151	96	47
Net debt (negative = net cash)	−14	−71	−193	−161	−123	−67	−23

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: OPRX vs SOPH CCLD vs SOPH AMWL vs SOPH HCTI vs SOPH

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Sophia Genetics SA's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sophia Genetics SA.